Rituximab
Apr 09, 2009 at 12:40 | Source: Moneycontrol.com
Nov 21, 2006 at 15:07
Photos »
/ 
News across the web »
Oct 18, 2011 at 21:02 | Source: The Hindu BusinessLine
Oct 18, 2011 at 16:42 | Source: NDTV Profit
Related News »
The trial is designed to enroll a total of 100 patients in North America, who will be randomized to one of two treatment arms: ZEVALIN + rituximab, and MGd, or ZEVALIN + rituximab. The treatment period will be 10-12 days, followed by 12-week ...
May 28, 2012 at 08:58 | Source: Yahoo Finance
(RTTNews) - Spectrum Pharmaceuticals (SPPI: News ) announced the initiation of a Phase 2 study evaluating ZEVALIN Injection for intravenous use + rituximab in combination with motexafin gadolinium or MGd in patients with rituximab-refractory low-grade or ...
May 17, 2012 at 11:27 | Source: RTT News
CHICAGO -- Adding the monoclonal antibody rituximab (Rituxan) to chemotherapy improves outcomes for HIV patients diagnosed with non-Hodgkin's lymphoma, researchers found. On the other hand, patients with a high score on the age-adjusted ...
May 26, 2012 at 13:53 | Source: MedPage Today
(Ivanhoe Newswire) – Although some anecdotal cases and studies report that the drug rituximab can benefit children that are resistant to standard treatment for idiopathic nephrotic syndrome (INS), a recent study unfortunately proves otherwise. INS is a ...
May 15, 2012 at 03:01 | Source: Ivanhoe
CYC treatment resulted in a decrease in Ig levels (median; interquartile range IQR) from IgG 12.8 g/L (8.15-15.45) to 9.17 g/L (8.04-9.90) (p = 0.002), IgM 1.05 g/L (0.70-1.41) to 0.83 g/L (0.60-1.17) (p = 0.046) and IgA 2.58 g/L (1.71-3.48) to 1 ...
May 21, 2012 at 22:13 | Source: Elites TV
The Italians are updating their data on R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) vs R-CVP (rituximab, cyclophosphamide, vincristine, and prednisone) vs R-FM (rituximab, fludarabine, and mitoxantrone).
May 22, 2012 at 23:52 | Source: Medscape News
Combining rituximab with prednisone and calcineurin inhibitors did not significantly lower the incidence of proteinuria among children with resistant idiopathic nephrotic syndrome at three months, an Italian study found. The finding, based on 31 patients ...
May 14, 2012 at 15:48 | Source: SmartBrief
Arzerra(r) net sales increased 32% over Q1 2011 New Drug Application for ofatumumab submitted in Japan Amended protocol for ofatumumab Phase III head to head study vs rituximab in DLBCL; moved estimated primary data readout forward Improved ...
May 15, 2012 at 15:18 | Source: msnbc.com
safety and efficacy data from the phase Ib CLL combination trial with bendamustine and rituximab in relapsed or refractory patients (PCYC-1108-CA). Pharmacyclics plans to issue a material update on the ibrutinib clinical development program and ...
May 22, 2012 at 09:48 | Source: Marketwatch